The FDA's regulation of pharmaceutical communications in the context of managed care: a suggested approach.
作者信息
Kuhlik B N
机构信息
Covington & Burling, Washington, D.C., USA.
出版信息
Food Drug Law J. 1995;50(1):23-48.
PMID:10342984
Abstract
摘要
相似文献
1
The FDA's regulation of pharmaceutical communications in the context of managed care: a suggested approach.
Food Drug Law J. 1995;50(1):23-48.
2
Targeting formulary pull-through strategies: the role of pharmaceutical manufacturers.
Manag Care Interface. 1999 May;12(5):84-6.
3
FDA considers effects of managed care marketplace on drug promotional practices.
Formulary. 1995 Dec;30(12):840-1.
4
The response to health care reform by the pharmaceutical industry.
Food Drug Law J. 1995;50(1):1-22.
5
Managed care pharmacy 101: learning from the students.
Manag Care Interface. 2005 Apr;18(4):28, 31.
6
7
Changing the marketing message.
Med Interface. 1995 Jun;8(6):83-5.
8
The FDA's accelerated approval process: does the pharmaceutical industry have adequate incentives for self-regulation?
Am J Law Med. 1999;25(4):543-68.
9
The Patient's Bill of Rights and the pharmacy benefit.
Manag Care Interface. 2000 Oct;13(10):80-1.
10
Injectable drugs: the new frontier in pharmacy management.
Am J Manag Care. 2003 Jun;Suppl Decision Maker News:5-8.
引用本文的文献
1
Why training is the key to successful guideline implementation.
Pharmacoeconomics. 1997 Sep;12(3):297-302. doi: 10.2165/00019053-199712030-00001.
Zotero 插件